✨ Health Notices
NEW ZEALAND GAZETTE, No. 76
24 APRIL 2008
Health
Crown Entities Act 2004
New Zealand Public Health and Disability Act 2000
Appointments to Whanganui District Health Board
Pursuant to section 29(1)(b) of the New Zealand Public Health and Disability Act 2000, and under section 28(2) of the Crown Entities Act 2004, I appoint
Nancy Te Urumanao Tuaine
as a member of the board of Whanganui District Health Board; and under clause 10(1) of Schedule 3 to the
New Zealand Public Health and Disability Act 2000,
I appoint
Ormond Brian Stock
as deputy chairperson of the board of Whanganui District Health Board.
These appointments take effect on 24 April 2008 and will end on 5 December 2010.
Dated at Wellington this 21st day of April 2008.
HON DAVID CUNLIFFE, Minister of Health.
go2852
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo – Quinapril
Active Ingredient:
Quinapril hydrochloride 10.832mg equivalent to 10mg quinapril
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Lupin Limited, Verna Industrial Area, Verna, Salcette, Goa, India
Product:
Apo – Quinapril
Active Ingredient:
Quinapril hydrochloride 21.664mg equivalent to 20mg quinapril
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Lupin Limited, Verna Industrial Area, Verna, Salcette, Goa, India
Product:
Apo – Quinapril
Active Ingredient:
Quinapril hydrochloride 5.416mg equivalent to 5mg quinapril
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Lupin Limited, Verna Industrial Area, Verna, Salcette, Goa, India
Product:
Bicalox
Active Ingredient:
Bicalutamide 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Douglas Manufacturing Limited, Lincoln, Auckland
Product:
Cephalexin ABM
Active Ingredient:
Cefalexin monohydrate equivalent to 250mg Cefalexin anhydrous
Dosage Form:
Capsule
New Zealand Sponsor:
ABM Pharma Limited
Manufacturer:
Lupin Limited, Mandideep, District Raisen, Madhya Pradesh, India
Product:
Cephalexin ABM
Active Ingredient:
Cefalexin monohydrate equivalent to 500mg Cefalexin anhydrous
Dosage Form:
Capsule
New Zealand Sponsor:
ABM Pharma Limited
Manufacturer:
Lupin Limited, Mandideep, District Raisen, Madhya Pradesh, India
Product:
Fluorescein Novartis
Active Ingredient:
Fluorescein sodium 500mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
B Braun Melsungen AG, Berlin, Germany
Product:
Oraqix Periodontal Gel
Active Ingredients:
Lidocaine 25mg/g
Prilocaine 25mg/g
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2008, No 76
Gazette.govt.nz —
NZ Gazette 2008, No 76
✨ LLM interpretation of page content
🏥 Appointments to Whanganui District Health Board
🏥 Health & Social Welfare21 April 2008
Appointments, District Health Board, Whanganui, Deputy Chairperson
- Nancy Te Urumanao Tuaine, Appointed member of the board
- Ormond Brian Stock, Appointed deputy chairperson of the board
- HON DAVID CUNLIFFE, Minister of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981
- Minister of Health